ID   L6-20-4
AC   CVCL_CW49
SY   L6
DR   ABCD; ABCD_AF498
DR   Wikidata; Q54901052
RX   Patent=US4906562;
RX   Patent=US4975278;
RX   Patent=US5204244;
RX   PubMed=3731064;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8677.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30408; Human TM4SF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 6
//
RX   Patent=US4906562;
RA   Hellstrom I., Brown J.P., Hellstrom K.E., Horn D., Linsley P.S.;
RT   "Monocolonal antibodies and antigen for human non-small cell lung
RT   carcinomas.";
RL   Patent number US4906562, 06-Mar-1990.
//
RX   Patent=US4975278;
RA   Senter P.D., Saulnier M.G., Brown J.P., Kerr D.E.;
RT   "Antibody-enzyme conjugates in combination with prodrugs for the
RT   delivery of cytotoxic agents to tumor cells.";
RL   Patent number US4975278, 04-Dec-1990.
//
RX   Patent=US5204244;
RA   Fell H.P., Folger-Bruce K.R.;
RT   "Production of chimeric antibodies by homologous recombination.";
RL   Patent number US5204244, 20-Apr-1993.
//
RX   PubMed=3731064;
RA   Hellstrom I., Horn D., Linsley P.S., Brown J.P., Brankovan V.,
RA   Hellstrom K.E.;
RT   "Monoclonal mouse antibodies raised against human lung carcinoma.";
RL   Cancer Res. 46:3917-3923(1986).
//